<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28927958</article-id>
<article-id pub-id-type="pmc">5696074</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2017.09.006</article-id>
<article-id pub-id-type="manuscript">NIHMS909092</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Defective GABAergic neurotransmission in the nucleus tractus solitarius in <italic>Mecp2</italic>-null mice, a model of Rett syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Chao-Yin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Di Lucente</surname>
<given-names>Jacopo</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Yen-Chu</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lien</surname>
<given-names>Cheng-Chang</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rogawski</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maezawa</surname>
<given-names>Izumi</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Lee-Way</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pharmacology, University of California Davis, One Shields Avenue, Davis, California 95616</aff>
<aff id="A2">
<label>2</label>Department of Pathology and Laboratory Medicine, University of California Davis, One Shields Avenue, Davis, California 95616</aff>
<aff id="A3">
<label>3</label>Department of Neurology, University of California Davis, One Shields Avenue, Davis, California 95616</aff>
<aff id="A4">
<label>4</label>M.I.N.D. (Medical Investigation of Neurodevelopmental Disorders) Institute, University of California Davis, One Shields Avenue, Davis, California 95616</aff>
<aff id="A5">
<label>5</label>Institute of Neuroscience, National Yang-Ming University, Taipei 112, Taiwan</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding authors: Lee-Way Jin, M.D., Ph.D. Dept. of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA 95817, Tel: 916-703-0292, Fax: 916-703-0370, <email>lwjin@ucdavis.edu</email>; Chao-Yin Chen, Ph.D. Dept. of Pharmacology, University of California, Davis, Davis, CA 95616, Tel: 530-754-6458, Fax: 530-752-7710, <email>cych@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>109</volume>
<issue>Pt A</issue>
<fpage>25</fpage>
<lpage>32</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2017.09.006-->
<abstract>
<p id="P1">Rett syndrome (RTT) is a devastating neurodevelopmental disorder caused by loss-of-function mutations in the X-linked methyl-CpG binding protein 2 (<italic>Mecp2</italic>) gene. GABAergic dysfunction has been implicated contributing to the respiratory dysfunction, one major clinical feature of RTT. The nucleus tractus solitarius (NTS) is the first central site integrating respiratory sensory information that can change the nature of the reflex output. We hypothesized that deficiency in <italic>Mecp2</italic> gene reduces GABAergic neurotransmission in the NTS. Using whole-cell patch-clamp recordings in NTS slices, we measured spontaneous inhibitory postsynaptic currents (sIPSCs), miniature IPSCs (mIPSCs), NTS-evoked IPSCs (eIPSCs), and GABA<sub>A</sub> receptor (GABA<sub>A</sub>-R) agonist-induced responses. Compared to those from wild-type mice, NTS neurons from <italic>Mecp2</italic>-null mice had significantly (<italic>p</italic>&lt;0.05) reduced sIPSC amplitude, sIPSC frequency, and mIPSC amplitude but not mIPSC frequency. <italic>Mecp2</italic>-null mice also had decreased eIPSC amplitude with no change in paired-pulse ratio. The data suggest reduced synaptic receptor-mediated phasic GABA transmission in <italic>Mecp2</italic>-null mice. In contrast, muscimol (GABA<sub>A</sub>-R agonist, 0.3 – 100 μM) and THIP (selective extrasynaptic GABA<sub>A</sub>-R agonist, 5 μM) induced significantly greater current response in <italic>Mecp2</italic>-null mice, suggesting increased extrasynaptic receptors. Using qPCR, we found a 2.5 fold increase in the delta subunit of the GABA<sub>A</sub>-Rs in the NTS in <italic>Mecp2</italic>-null mice, consistent with increased extrasynaptic receptors. As the NTS was recently found required for respiratory pathology in RTT, our results provide a mechanism for NTS dysfunction which involves shifting the balance of synaptic/extrasynaptic receptors in favor of extrasynaptic site, providing a target for boosting GABAergic inhibition in RTT.</p>
</abstract>
<kwd-group>
<kwd>NTS</kwd>
<kwd>GABA</kwd>
<kwd>Rett syndrome</kwd>
<kwd>Extrasynaptic receptors</kwd>
<kwd>patch clamp</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>